Deep Learning Market Overview The deep learning market (for healthcare and drug discovery) is estimated to be $34.5 billion in 2023 and is expected to grow at a CAGR of 21.9% during the forecast period. Since the mid-twentieth century, computing devices have continually been explored for applications beyond mere calculations, to emerge as machines that possess intelligence. These targeted efforts have led to the emergence of artificial intelligence, the next-generation simulator that emplo
...read more4D Bioprinting Market Overview The 4D bioprinting market is estimated to be worth $21 million in 2023 and is expected to grow at compounded annual growth rate (CAGR) of 34.0% during the forecast period. The concept of 3D printing has been one of the biggest revolutions across the globe. Various industry stakeholders and academicians have undertaken several initiatives to further develop / improve this technology for a variety of applications. One such application area is 3D bioprinting that i
...read moreBiopreservation Market Overview The biopreservation market for media is estimated to be worth $800 million in 2022 and is expected to grow at compounded annual growth rate (CAGR) of 23.6% during the forecast period. Over the past few years, there has been an evident growth in the pipeline of cell-based products, fueled by the demand for effective therapeutics. However, such products are often temperature sensitive, requiring freezing / cryogenic conditions for transport and storage. In f
...read moreLyophilization Services Market Overview The lyophilization services market is estimated to be worth $2.2 billion in 2022 and is expected to grow at compounded annual growth rate (CAGR) of 6.8% during the forecast period. Over the last decade, a steady rise has been observed in the annual number of approvals for various types of biologics (including monoclonal antibodies, cell therapies, recombinant proteins, vaccines and gene therapies). In addition, more than 8,000 biological therapeuti
...read moreSpectrometry Market Overview The novel spectrometry market (instruments) is estimated to be worth $4.6 billion in 2022 and is expected to grow at compounded annual growth rate (CAGR) of 8% during the forecast period, with mass spectrometry market holding the largest market share. Over time, spectroscopy has emerged as an important analytical tool for accurate and rapid analysis of compounds. It finds applications in research activities in food, biotechnology, pharmaceutical and environmental
...read moreCell and Gene Therapy CRO Market The cell and gene therapy CRO market is estimated to be worth $713 million in 2022 and is expected to grow at compounded annual growth rate (CAGR) of 18% during the forecast period. Cell and gene therapy have been demonstrated to have the potential to treat complex and rare diseases, including indications, for which no effective treatment is currently available. In this context, it is important to mention that, in case of cell therapy, human cells are tra
...read moreOligonucleotide Synthesis Market Overview The oligonucleotide synthesis market is estimated to be worth $2.2 billion and is expected to grow at CAGR of 17.8% during the forecast period. Post the marketing of Vitravene®, the first antisense oligonucleotide-based therapy to receive approval (in 1998), various stakeholders have undertaken multiple research initiatives to verify the potential of oligonucleotides as therapeutic agents. The known applications of oligonucleotides in re
...read moreNext Generation Drug Conjugates Market Overview The global market for the next generation drug conjugates is expected to grow from US$ 2.40 billion in 2023 to US$ 15.47 billion in 2035, growing at CAGR of more than 20% during the forecast period. The next generation drug conjugates, owing to their non-immunogenic nature, better clinical profile, structural stability, limited side effects, targeted delivery of payload, deeper cellular penetration, and permeability, have emerged as th
...read moreAt Home Blood Collection Devices Market The at home blood collection devices market is estimated to be worth $747 million in 2021 and is expected to grow at CAGR of 10.7% during the forecast period. Post the onset of COVID-19 pandemic, there has been a decline in number of patients visiting laboratories for sample collection and testing. Owing to the risk of infection associated with such places, several patients postponed their routine tests and medical checkups, in order to avoid the s
...read moreRNA Therapeutics and RNA Vaccines Market Overview The global RNA Vaccines and RNA Therapeutics market is estimated to be worth over USD 948 million in 2035 and is expected to grow at compounded annual growth rate (CAGR) of 50% during the forecast period (2026-2035). In the past few years, RNA based therapeutics have emerged as one of the key therapeutic modalities in the modern healthcare industry. These RNA based therapeutics play a crucial role in protein production and regulation of g
...read morePlasma Fractionation Market Overview The global plasma fractionation market is estimated to be worth US$ 12.70 billion in 2035 with an estimated compounded annual growth rate (CAGR) of ~10% during the forecast period of 2023-2035. Over the past two decades, the number of patients affected with rare diseases have increased tremendously. In fact, over 410 million people are currently suffering from rare and chronic disorders. Given the growing prevalence of the aforementioned disorder
...read moreDrug Device Combination Products Market The drug device combination products market (services) is estimated to be worth $252 million in 2022 and is expected to grow at compounded annual growth rate (CAGR) of 10% during the forecast period. Non-adherence to prescribed medication regimen is one of the major factors that not only causes negative implications on the patient’s health, but also adds to the overall pharmaceutical industry’s burden. According to an article published by Co
...read moreDigital Twin Market Overview The digital twin market in healthcare and pharmaceutical industry is estimated to be around USD 1 billion in 2022 and is growing at a healthy compounded annual growth rate (CAGR) of 30% during the forecast period. The research and development behind a new drug is reported to require, on an average, an investment of nearly USD 1 billion. At present, over 90% of the drug candidates fail across different stages of clinical trials, leading to significant fin
...read moreClinical Trial Patient Recruitment Services Overview The global clinical trial patient recruitment services market was valued at USD 9.4 billion in 2022; it is estimated to grow at compounded annual growth rate (CAGR) of 8.2% during the forecast period. Clinical trials form an integral part of the overall drug development process, enabling the necessary evaluation of the safety and efficacy of a drug candidate. As these trials are prone to delays, and can even fail altogether, they impose an
...read moreAI In Oncology Market Overview The AI in oncology market is estimated to be worth $1.1 billion in 2023 and is expected to grow to $9.1 billion by 2035. Cancer is the one of the leading cause of deaths, globally, as per the World Health Organization (WHO). Annual statistics reported by the American Cancer Society (ACR) indicate that, in 2022, around 1.9 million individuals are likely to be diagnosed with various types of cancer in the US. During the same year, around 0.6 million cancer-re
...read moreNutrigenomics Market Overview The nutrigenomics market is estimated to be worth $0.64 billion in 2022 and is expected to grow at a compounded annual growth rate (CAGR) of 13% during the forecast period. Given the recent shift from the one-size-fits-all model to a more personalized mode of treatment, there has been a growing interest in identification and adoption of novel techniques. It is estimated that there are around 20,000 genes present in the human body, all of which interact with th
...read moreTIL Therapy Overview The global TIL therapy market is estimated to be worth $0.09 billion in 2023 and is expected to grow at compounded annual growth rate (CAGR) of 40% during the forecast period. The global TIL therapy market is a growing market within the cell therapy market and is estimated to grow at a CAGR of 40% during the forecast period. Over the years, various studies have validated the successful use of tumor infiltrating lymphocytes (TILs) in treating patients diagnosed w
...read moreDigital Therapeutics Market Overview The global digital therapeutics market is anticipated to grow at a compound annual growth rate (CAGR) of 20% during the period 2022 – 2035 and is expected to be worth around USD 20 billion by 2035. Digital Therapeutics, popularly known as DTx, represent a digital health solution which delivers medical interventions directly to the patients in order to treat, manage and prevent a disease. Such solutions usually employ evidence based and clinically val
...read more3D Cell Culture Market Overview The 3D cell culture market is estimated to be worth $1.2 billion in 2022 and is expected to grow at compounded annual growth rate (CAGR) of 16.7% during the forecast period. Animal testing has been the most common method in various experimental studies in biomedical research, given their resemblance to humans in terms of genetics, anatomy, and physiology. Specifically, mice genome has 80% similarity with humans, which makes them excellent models for variou
...read moreExosomes Development and Exosomes Manufacturing Market Overview The exosomes development and exosomes manufacturing market is estimated to be worth $15 million in 2022 and is expected to grow at compounded annual growth rate (CAGR) of 18% during the forecast period. Exosomes are extracellular vesicles that play an important role in cell-to-cell communication and act as carriers of circulating nucleic acids, lipids and proteins in body. Over time, various research studies have demonstrate
...read moreCHOOSE CATEGORY
We are your partners with no equity
We fit in your budget
We love what we do
Chance to prove ourselves
Best in class quality of work
Most trusted consulting partner in the industry
SUBSCRIBE TO INDUSTRY UPDATES